Affimed NV is a biotechnology company that focuses on developing immunotherapies for cancer treatment. The company specializes in creating antibody-based therapies aimed at enhancing the body’s immune response against cancerous cells.
2000
Germany
51 - 200 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Industry rank: 17 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 17 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▼ 6.2%
0.0
▲ 3.3%
0.0
▼ 22.2%
Not available
Available
Not available
Available
7 out of 13 incl. management
Not available
Not available
Available
Not available
Not available
Not available
Not available